Technical Data
14 Jul 2022

Rhodiola rosea review

The Natac scientific team lead by José Carlos Quintela have just published a review of Rhodiola rosea in the medical journal Molecules (MDPI) in June.

The literature analysis reviews 21 separate clinical studies into rhodiola’s effectiveness and discusses the plants activity across the five key areas of: neuroprotection, anxiety and depression, physical strength and, endurance, cardio protection and reproduction.

Rhodiola´s properties as an adaptogen are discussed and its major phytochemical constituents of rosavins and salidroside are brought into clinical focus.

Content provided by our supplier

Natac

  • ES
  • 2020
    On CPHI since
  • 5
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Intermediates Manufacturer
Natural Extracts
Nutraceuticals

Other Content from Natac (3)

  • News Rhodiola rosea review

    The Natac scientific team led by José Carlos Quintela have just published a review of Rhodiola rosea in the medical journal Molecules (MDPI) in June.
  • Brochure Pharmaceutical Plant Extract Solutions

    In healthcare today, patients need to feel like they can trust the medicinal products they use. That’s why all of our compounds are derived from 100% natural, premium-quality botanicals.

    With all of the documentation necessary for Active Pharmaceutical Ingredients (API’s) in medicinal products, we guarantee our extracts comply with all the pharmaceutical sector regulations.

    Our standards for quality are the best in the world. Still, the new Hervás factory has tripled our production capacity, making us world leaders in both quantity and quality of natural ingredients.

  • Video Natac Company Presentation

    Company presentation showcasing how Natac uniquely provides botanical plant extracts to the pharmaceutical, nutraceutical, food, animal feed and cosmetic sectors.